Ryanodine receptor signaling is required for anti-CD3-induced T cell proliferation, interleukin-2 synthesis, and interleukin-2 receptor signaling

Ryanodine receptors (RyR) are involved in regulating intracellular Ca++ mobilization in T lymphocytes. However, the importance of RyR signaling during T cell activation has not yet been determined. In this study, we have used the RyR‐selective antagonists, ruthenium red and dantrolene, to determine...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular biochemistry 2004-05, Vol.92 (2), p.387-399
Hauptverfasser: Conrad, David M., Hanniman, Elyisha A., Watson, Carrie L., Mader, Jamie S., Hoskin, David W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 399
container_issue 2
container_start_page 387
container_title Journal of cellular biochemistry
container_volume 92
creator Conrad, David M.
Hanniman, Elyisha A.
Watson, Carrie L.
Mader, Jamie S.
Hoskin, David W.
description Ryanodine receptors (RyR) are involved in regulating intracellular Ca++ mobilization in T lymphocytes. However, the importance of RyR signaling during T cell activation has not yet been determined. In this study, we have used the RyR‐selective antagonists, ruthenium red and dantrolene, to determine the effect of RyR blockade on T cell receptor‐mediated activation events and cytokine‐dependent T cell proliferation. Both ruthenium red and dantrolene inhibited DNA synthesis and cell division, as well as the synthesis of interleukin (IL)‐2 by T lymphocytes responding to mitogenic anti‐CD3 antibody. Blockade of RyR at initiation of culture or as late as 24 h after T cell receptor stimulation inhibited T cell proliferation, suggesting a requirement for sustained RyR signaling during cell cycle progression. Although flow cytometry revealed that RyR blockade had little effect on activation‐induced expression of the α chain (CD25) of the high affinity IL‐2 receptor, the inhibitory effect of RyR antagonists could not be reversed by the addition of exogenous IL‐2 at initiation of culture. In addition, both ruthenium red and dantrolene had a strong inhibitory effect on IL‐2‐dependent proliferation of CTLL‐2 T cells. These data indicate that RyR are involved in regulating IL‐2 receptor signaling that drives T cell progression through the cell cycle. We conclude that RyR‐associated Ca++ signaling regulates T cell proliferation by promoting both IL‐2 synthesis and IL‐2‐dependent cell cycle progression. © 2004 Wiley‐Liss, Inc.
doi_str_mv 10.1002/jcb.20064
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71866755</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20794654</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3924-8e4bd69aa7e88e1e21e42b3d60abebb4afe19d5fbff85b8eff4ca18316fdcbb33</originalsourceid><addsrcrecordid>eNqFkd1u1DAQhS0EokvhghdAuUJCqlv_xUkuaYCUagUSWuDSsuNxcZt1tnYi2Mfgjet2lyKBEFcjzXznzIwOQs8pOaaEsJPL3hwzQqR4gBaUNBUWUoiHaEEqTjDjlB2gJyldEkKahrPH6ICWlNRc8gX6-Wmrw2h9gCJCD5tpjEXyF0EPPlwUPuXu9ewj2MLliQ6Tx-0bjn2wc5-bq6KHYSg2cRy8g6gnP4ajwocJ4gDzlQ-YFWkbpm-QfDrKevvH8O-lT9Ejp4cEz_b1EH1-93bVnuHlx-59-3qJe94wgWsQxspG6wrqGigwCoIZbiXRBowR2gFtbOmMc3VpanBO9JrWnEpne2M4P0Qvd775-OsZ0qTWPt1-owOMc1IVraWsyvK_ICNVI2QpMvhqB_ZxTCmCU5vo1zpuFSXqNiiVg1J3QWX2xd50Nmuwv8l9Mhk42QHf_QDbfzup8_b0lyXeKXya4Me9QscrJStelerrh06dfelatlx1quM3Ou-vyA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20794654</pqid></control><display><type>article</type><title>Ryanodine receptor signaling is required for anti-CD3-induced T cell proliferation, interleukin-2 synthesis, and interleukin-2 receptor signaling</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Conrad, David M. ; Hanniman, Elyisha A. ; Watson, Carrie L. ; Mader, Jamie S. ; Hoskin, David W.</creator><creatorcontrib>Conrad, David M. ; Hanniman, Elyisha A. ; Watson, Carrie L. ; Mader, Jamie S. ; Hoskin, David W.</creatorcontrib><description>Ryanodine receptors (RyR) are involved in regulating intracellular Ca++ mobilization in T lymphocytes. However, the importance of RyR signaling during T cell activation has not yet been determined. In this study, we have used the RyR‐selective antagonists, ruthenium red and dantrolene, to determine the effect of RyR blockade on T cell receptor‐mediated activation events and cytokine‐dependent T cell proliferation. Both ruthenium red and dantrolene inhibited DNA synthesis and cell division, as well as the synthesis of interleukin (IL)‐2 by T lymphocytes responding to mitogenic anti‐CD3 antibody. Blockade of RyR at initiation of culture or as late as 24 h after T cell receptor stimulation inhibited T cell proliferation, suggesting a requirement for sustained RyR signaling during cell cycle progression. Although flow cytometry revealed that RyR blockade had little effect on activation‐induced expression of the α chain (CD25) of the high affinity IL‐2 receptor, the inhibitory effect of RyR antagonists could not be reversed by the addition of exogenous IL‐2 at initiation of culture. In addition, both ruthenium red and dantrolene had a strong inhibitory effect on IL‐2‐dependent proliferation of CTLL‐2 T cells. These data indicate that RyR are involved in regulating IL‐2 receptor signaling that drives T cell progression through the cell cycle. We conclude that RyR‐associated Ca++ signaling regulates T cell proliferation by promoting both IL‐2 synthesis and IL‐2‐dependent cell cycle progression. © 2004 Wiley‐Liss, Inc.</description><identifier>ISSN: 0730-2312</identifier><identifier>EISSN: 1097-4644</identifier><identifier>DOI: 10.1002/jcb.20064</identifier><identifier>PMID: 15108363</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Animals ; Antibodies - immunology ; Antibodies - pharmacology ; calcium ; Calcium - metabolism ; CD3 Complex - metabolism ; Cell Proliferation - drug effects ; Cells, Cultured ; DNA - biosynthesis ; Female ; interleukin-2 ; Interleukin-2 - biosynthesis ; Interleukin-2 - immunology ; Interleukin-2 - pharmacology ; Mice ; Mice, Inbred C57BL ; Receptors, Interleukin-2 - metabolism ; Ruthenium Red - pharmacology ; ryanodine receptor ; Ryanodine Receptor Calcium Release Channel - metabolism ; Signal Transduction - drug effects ; T lymphocyte ; T-Lymphocytes - cytology ; T-Lymphocytes - drug effects ; T-Lymphocytes - immunology ; T-Lymphocytes - metabolism</subject><ispartof>Journal of cellular biochemistry, 2004-05, Vol.92 (2), p.387-399</ispartof><rights>Copyright © 2004 Wiley‐Liss, Inc.</rights><rights>Copyright 2004 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3924-8e4bd69aa7e88e1e21e42b3d60abebb4afe19d5fbff85b8eff4ca18316fdcbb33</citedby><cites>FETCH-LOGICAL-c3924-8e4bd69aa7e88e1e21e42b3d60abebb4afe19d5fbff85b8eff4ca18316fdcbb33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjcb.20064$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjcb.20064$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15108363$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Conrad, David M.</creatorcontrib><creatorcontrib>Hanniman, Elyisha A.</creatorcontrib><creatorcontrib>Watson, Carrie L.</creatorcontrib><creatorcontrib>Mader, Jamie S.</creatorcontrib><creatorcontrib>Hoskin, David W.</creatorcontrib><title>Ryanodine receptor signaling is required for anti-CD3-induced T cell proliferation, interleukin-2 synthesis, and interleukin-2 receptor signaling</title><title>Journal of cellular biochemistry</title><addtitle>J. Cell. Biochem</addtitle><description>Ryanodine receptors (RyR) are involved in regulating intracellular Ca++ mobilization in T lymphocytes. However, the importance of RyR signaling during T cell activation has not yet been determined. In this study, we have used the RyR‐selective antagonists, ruthenium red and dantrolene, to determine the effect of RyR blockade on T cell receptor‐mediated activation events and cytokine‐dependent T cell proliferation. Both ruthenium red and dantrolene inhibited DNA synthesis and cell division, as well as the synthesis of interleukin (IL)‐2 by T lymphocytes responding to mitogenic anti‐CD3 antibody. Blockade of RyR at initiation of culture or as late as 24 h after T cell receptor stimulation inhibited T cell proliferation, suggesting a requirement for sustained RyR signaling during cell cycle progression. Although flow cytometry revealed that RyR blockade had little effect on activation‐induced expression of the α chain (CD25) of the high affinity IL‐2 receptor, the inhibitory effect of RyR antagonists could not be reversed by the addition of exogenous IL‐2 at initiation of culture. In addition, both ruthenium red and dantrolene had a strong inhibitory effect on IL‐2‐dependent proliferation of CTLL‐2 T cells. These data indicate that RyR are involved in regulating IL‐2 receptor signaling that drives T cell progression through the cell cycle. We conclude that RyR‐associated Ca++ signaling regulates T cell proliferation by promoting both IL‐2 synthesis and IL‐2‐dependent cell cycle progression. © 2004 Wiley‐Liss, Inc.</description><subject>Animals</subject><subject>Antibodies - immunology</subject><subject>Antibodies - pharmacology</subject><subject>calcium</subject><subject>Calcium - metabolism</subject><subject>CD3 Complex - metabolism</subject><subject>Cell Proliferation - drug effects</subject><subject>Cells, Cultured</subject><subject>DNA - biosynthesis</subject><subject>Female</subject><subject>interleukin-2</subject><subject>Interleukin-2 - biosynthesis</subject><subject>Interleukin-2 - immunology</subject><subject>Interleukin-2 - pharmacology</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Receptors, Interleukin-2 - metabolism</subject><subject>Ruthenium Red - pharmacology</subject><subject>ryanodine receptor</subject><subject>Ryanodine Receptor Calcium Release Channel - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>T lymphocyte</subject><subject>T-Lymphocytes - cytology</subject><subject>T-Lymphocytes - drug effects</subject><subject>T-Lymphocytes - immunology</subject><subject>T-Lymphocytes - metabolism</subject><issn>0730-2312</issn><issn>1097-4644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkd1u1DAQhS0EokvhghdAuUJCqlv_xUkuaYCUagUSWuDSsuNxcZt1tnYi2Mfgjet2lyKBEFcjzXznzIwOQs8pOaaEsJPL3hwzQqR4gBaUNBUWUoiHaEEqTjDjlB2gJyldEkKahrPH6ICWlNRc8gX6-Wmrw2h9gCJCD5tpjEXyF0EPPlwUPuXu9ewj2MLliQ6Tx-0bjn2wc5-bq6KHYSg2cRy8g6gnP4ajwocJ4gDzlQ-YFWkbpm-QfDrKevvH8O-lT9Ejp4cEz_b1EH1-93bVnuHlx-59-3qJe94wgWsQxspG6wrqGigwCoIZbiXRBowR2gFtbOmMc3VpanBO9JrWnEpne2M4P0Qvd775-OsZ0qTWPt1-owOMc1IVraWsyvK_ICNVI2QpMvhqB_ZxTCmCU5vo1zpuFSXqNiiVg1J3QWX2xd50Nmuwv8l9Mhk42QHf_QDbfzup8_b0lyXeKXya4Me9QscrJStelerrh06dfelatlx1quM3Ou-vyA</recordid><startdate>20040515</startdate><enddate>20040515</enddate><creator>Conrad, David M.</creator><creator>Hanniman, Elyisha A.</creator><creator>Watson, Carrie L.</creator><creator>Mader, Jamie S.</creator><creator>Hoskin, David W.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20040515</creationdate><title>Ryanodine receptor signaling is required for anti-CD3-induced T cell proliferation, interleukin-2 synthesis, and interleukin-2 receptor signaling</title><author>Conrad, David M. ; Hanniman, Elyisha A. ; Watson, Carrie L. ; Mader, Jamie S. ; Hoskin, David W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3924-8e4bd69aa7e88e1e21e42b3d60abebb4afe19d5fbff85b8eff4ca18316fdcbb33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Antibodies - immunology</topic><topic>Antibodies - pharmacology</topic><topic>calcium</topic><topic>Calcium - metabolism</topic><topic>CD3 Complex - metabolism</topic><topic>Cell Proliferation - drug effects</topic><topic>Cells, Cultured</topic><topic>DNA - biosynthesis</topic><topic>Female</topic><topic>interleukin-2</topic><topic>Interleukin-2 - biosynthesis</topic><topic>Interleukin-2 - immunology</topic><topic>Interleukin-2 - pharmacology</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Receptors, Interleukin-2 - metabolism</topic><topic>Ruthenium Red - pharmacology</topic><topic>ryanodine receptor</topic><topic>Ryanodine Receptor Calcium Release Channel - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>T lymphocyte</topic><topic>T-Lymphocytes - cytology</topic><topic>T-Lymphocytes - drug effects</topic><topic>T-Lymphocytes - immunology</topic><topic>T-Lymphocytes - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Conrad, David M.</creatorcontrib><creatorcontrib>Hanniman, Elyisha A.</creatorcontrib><creatorcontrib>Watson, Carrie L.</creatorcontrib><creatorcontrib>Mader, Jamie S.</creatorcontrib><creatorcontrib>Hoskin, David W.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Conrad, David M.</au><au>Hanniman, Elyisha A.</au><au>Watson, Carrie L.</au><au>Mader, Jamie S.</au><au>Hoskin, David W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ryanodine receptor signaling is required for anti-CD3-induced T cell proliferation, interleukin-2 synthesis, and interleukin-2 receptor signaling</atitle><jtitle>Journal of cellular biochemistry</jtitle><addtitle>J. Cell. Biochem</addtitle><date>2004-05-15</date><risdate>2004</risdate><volume>92</volume><issue>2</issue><spage>387</spage><epage>399</epage><pages>387-399</pages><issn>0730-2312</issn><eissn>1097-4644</eissn><abstract>Ryanodine receptors (RyR) are involved in regulating intracellular Ca++ mobilization in T lymphocytes. However, the importance of RyR signaling during T cell activation has not yet been determined. In this study, we have used the RyR‐selective antagonists, ruthenium red and dantrolene, to determine the effect of RyR blockade on T cell receptor‐mediated activation events and cytokine‐dependent T cell proliferation. Both ruthenium red and dantrolene inhibited DNA synthesis and cell division, as well as the synthesis of interleukin (IL)‐2 by T lymphocytes responding to mitogenic anti‐CD3 antibody. Blockade of RyR at initiation of culture or as late as 24 h after T cell receptor stimulation inhibited T cell proliferation, suggesting a requirement for sustained RyR signaling during cell cycle progression. Although flow cytometry revealed that RyR blockade had little effect on activation‐induced expression of the α chain (CD25) of the high affinity IL‐2 receptor, the inhibitory effect of RyR antagonists could not be reversed by the addition of exogenous IL‐2 at initiation of culture. In addition, both ruthenium red and dantrolene had a strong inhibitory effect on IL‐2‐dependent proliferation of CTLL‐2 T cells. These data indicate that RyR are involved in regulating IL‐2 receptor signaling that drives T cell progression through the cell cycle. We conclude that RyR‐associated Ca++ signaling regulates T cell proliferation by promoting both IL‐2 synthesis and IL‐2‐dependent cell cycle progression. © 2004 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>15108363</pmid><doi>10.1002/jcb.20064</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0730-2312
ispartof Journal of cellular biochemistry, 2004-05, Vol.92 (2), p.387-399
issn 0730-2312
1097-4644
language eng
recordid cdi_proquest_miscellaneous_71866755
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Animals
Antibodies - immunology
Antibodies - pharmacology
calcium
Calcium - metabolism
CD3 Complex - metabolism
Cell Proliferation - drug effects
Cells, Cultured
DNA - biosynthesis
Female
interleukin-2
Interleukin-2 - biosynthesis
Interleukin-2 - immunology
Interleukin-2 - pharmacology
Mice
Mice, Inbred C57BL
Receptors, Interleukin-2 - metabolism
Ruthenium Red - pharmacology
ryanodine receptor
Ryanodine Receptor Calcium Release Channel - metabolism
Signal Transduction - drug effects
T lymphocyte
T-Lymphocytes - cytology
T-Lymphocytes - drug effects
T-Lymphocytes - immunology
T-Lymphocytes - metabolism
title Ryanodine receptor signaling is required for anti-CD3-induced T cell proliferation, interleukin-2 synthesis, and interleukin-2 receptor signaling
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T13%3A57%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ryanodine%20receptor%20signaling%20is%20required%20for%20anti-CD3-induced%20T%20cell%20proliferation,%20interleukin-2%20synthesis,%20and%20interleukin-2%20receptor%20signaling&rft.jtitle=Journal%20of%20cellular%20biochemistry&rft.au=Conrad,%20David%20M.&rft.date=2004-05-15&rft.volume=92&rft.issue=2&rft.spage=387&rft.epage=399&rft.pages=387-399&rft.issn=0730-2312&rft.eissn=1097-4644&rft_id=info:doi/10.1002/jcb.20064&rft_dat=%3Cproquest_cross%3E20794654%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20794654&rft_id=info:pmid/15108363&rfr_iscdi=true